AKRO Investors Have the Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit
Akero(AKRO) Prnewswire·2024-06-22 22:30
NEW YORK, June 22, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of all purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ: AKRO) between September 13, 2022 and October 9, 2023. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by June 25, 2024.To join the Akero class action, go to https://rosenlegal.com/submit-form/?case_id=24557 or call Phill ...